Copyright Reports & Markets. All rights reserved.

Global Contraceptives Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Contraceptives Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Pills
    • 1.3.3 Injectable
    • 1.3.4 Condoms
    • 1.3.5 Vaginal Rings
    • 1.3.6 IUDs
    • 1.3.7 Subdermal Implants
    • 1.3.8 Others
  • 1.4 Market Analysis by End User
    • 1.4.1 Overview: Global Contraceptives Consumption Value by End User: 2020 Versus 2024 Versus 2031
    • 1.4.2 15–24 years
    • 1.4.3 25–34 years
    • 1.4.4 35–44 years
    • 1.4.5 Above 44 years
  • 1.5 Global Contraceptives Market Size & Forecast
    • 1.5.1 Global Contraceptives Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Contraceptives Sales Quantity (2020-2031)
    • 1.5.3 Global Contraceptives Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Bayer AG
    • 2.1.1 Bayer AG Details
    • 2.1.2 Bayer AG Major Business
    • 2.1.3 Bayer AG Contraceptives Product and Services
    • 2.1.4 Bayer AG Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Bayer AG Recent Developments/Updates
  • 2.2 Pfizer, Inc
    • 2.2.1 Pfizer, Inc Details
    • 2.2.2 Pfizer, Inc Major Business
    • 2.2.3 Pfizer, Inc Contraceptives Product and Services
    • 2.2.4 Pfizer, Inc Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Pfizer, Inc Recent Developments/Updates
  • 2.3 Teva Pharmaceutical Industries Ltd
    • 2.3.1 Teva Pharmaceutical Industries Ltd Details
    • 2.3.2 Teva Pharmaceutical Industries Ltd Major Business
    • 2.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Product and Services
    • 2.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
  • 2.4 Merck & Co., Inc
    • 2.4.1 Merck & Co., Inc Details
    • 2.4.2 Merck & Co., Inc Major Business
    • 2.4.3 Merck & Co., Inc Contraceptives Product and Services
    • 2.4.4 Merck & Co., Inc Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Merck & Co., Inc Recent Developments/Updates
  • 2.5 Actavis, Inc.
    • 2.5.1 Actavis, Inc. Details
    • 2.5.2 Actavis, Inc. Major Business
    • 2.5.3 Actavis, Inc. Contraceptives Product and Services
    • 2.5.4 Actavis, Inc. Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Actavis, Inc. Recent Developments/Updates
  • 2.6 Johnson & Johnson
    • 2.6.1 Johnson & Johnson Details
    • 2.6.2 Johnson & Johnson Major Business
    • 2.6.3 Johnson & Johnson Contraceptives Product and Services
    • 2.6.4 Johnson & Johnson Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Johnson & Johnson Recent Developments/Updates
  • 2.7 Gedeon Richter
    • 2.7.1 Gedeon Richter Details
    • 2.7.2 Gedeon Richter Major Business
    • 2.7.3 Gedeon Richter Contraceptives Product and Services
    • 2.7.4 Gedeon Richter Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Gedeon Richter Recent Developments/Updates
  • 2.8 Novo Nordisk A/S
    • 2.8.1 Novo Nordisk A/S Details
    • 2.8.2 Novo Nordisk A/S Major Business
    • 2.8.3 Novo Nordisk A/S Contraceptives Product and Services
    • 2.8.4 Novo Nordisk A/S Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Novo Nordisk A/S Recent Developments/Updates
  • 2.9 ZiZhu
    • 2.9.1 ZiZhu Details
    • 2.9.2 ZiZhu Major Business
    • 2.9.3 ZiZhu Contraceptives Product and Services
    • 2.9.4 ZiZhu Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 ZiZhu Recent Developments/Updates
  • 2.10 Baijingyu
    • 2.10.1 Baijingyu Details
    • 2.10.2 Baijingyu Major Business
    • 2.10.3 Baijingyu Contraceptives Product and Services
    • 2.10.4 Baijingyu Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Baijingyu Recent Developments/Updates
  • 2.11 Huazhong
    • 2.11.1 Huazhong Details
    • 2.11.2 Huazhong Major Business
    • 2.11.3 Huazhong Contraceptives Product and Services
    • 2.11.4 Huazhong Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Huazhong Recent Developments/Updates
  • 2.12 Sine
    • 2.12.1 Sine Details
    • 2.12.2 Sine Major Business
    • 2.12.3 Sine Contraceptives Product and Services
    • 2.12.4 Sine Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Sine Recent Developments/Updates
  • 2.13 Reckitt
    • 2.13.1 Reckitt Details
    • 2.13.2 Reckitt Major Business
    • 2.13.3 Reckitt Contraceptives Product and Services
    • 2.13.4 Reckitt Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Reckitt Recent Developments/Updates
  • 2.14 AbbVie
    • 2.14.1 AbbVie Details
    • 2.14.2 AbbVie Major Business
    • 2.14.3 AbbVie Contraceptives Product and Services
    • 2.14.4 AbbVie Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 AbbVie Recent Developments/Updates
  • 2.15 Church & Dwight
    • 2.15.1 Church & Dwight Details
    • 2.15.2 Church & Dwight Major Business
    • 2.15.3 Church & Dwight Contraceptives Product and Services
    • 2.15.4 Church & Dwight Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Church & Dwight Recent Developments/Updates
  • 2.16 The Cooper Companies
    • 2.16.1 The Cooper Companies Details
    • 2.16.2 The Cooper Companies Major Business
    • 2.16.3 The Cooper Companies Contraceptives Product and Services
    • 2.16.4 The Cooper Companies Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 The Cooper Companies Recent Developments/Updates
  • 2.17 TherapeuticsMD
    • 2.17.1 TherapeuticsMD Details
    • 2.17.2 TherapeuticsMD Major Business
    • 2.17.3 TherapeuticsMD Contraceptives Product and Services
    • 2.17.4 TherapeuticsMD Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 TherapeuticsMD Recent Developments/Updates
  • 2.18 Afaxys
    • 2.18.1 Afaxys Details
    • 2.18.2 Afaxys Major Business
    • 2.18.3 Afaxys Contraceptives Product and Services
    • 2.18.4 Afaxys Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Afaxys Recent Developments/Updates
  • 2.19 Mithra Pharmaceuticals
    • 2.19.1 Mithra Pharmaceuticals Details
    • 2.19.2 Mithra Pharmaceuticals Major Business
    • 2.19.3 Mithra Pharmaceuticals Contraceptives Product and Services
    • 2.19.4 Mithra Pharmaceuticals Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 Mithra Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Contraceptives by Manufacturer

  • 3.1 Global Contraceptives Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Contraceptives Revenue by Manufacturer (2020-2025)
  • 3.3 Global Contraceptives Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Contraceptives by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Contraceptives Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Contraceptives Manufacturer Market Share in 2024
  • 3.5 Contraceptives Market: Overall Company Footprint Analysis
    • 3.5.1 Contraceptives Market: Region Footprint
    • 3.5.2 Contraceptives Market: Company Product Type Footprint
    • 3.5.3 Contraceptives Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Contraceptives Market Size by Region
    • 4.1.1 Global Contraceptives Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Contraceptives Consumption Value by Region (2020-2031)
    • 4.1.3 Global Contraceptives Average Price by Region (2020-2031)
  • 4.2 North America Contraceptives Consumption Value (2020-2031)
  • 4.3 Europe Contraceptives Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Contraceptives Consumption Value (2020-2031)
  • 4.5 South America Contraceptives Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Contraceptives Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Contraceptives Sales Quantity by Type (2020-2031)
  • 5.2 Global Contraceptives Consumption Value by Type (2020-2031)
  • 5.3 Global Contraceptives Average Price by Type (2020-2031)

6 Market Segment by End User

  • 6.1 Global Contraceptives Sales Quantity by End User (2020-2031)
  • 6.2 Global Contraceptives Consumption Value by End User (2020-2031)
  • 6.3 Global Contraceptives Average Price by End User (2020-2031)

7 North America

  • 7.1 North America Contraceptives Sales Quantity by Type (2020-2031)
  • 7.2 North America Contraceptives Sales Quantity by End User (2020-2031)
  • 7.3 North America Contraceptives Market Size by Country
    • 7.3.1 North America Contraceptives Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Contraceptives Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Contraceptives Sales Quantity by Type (2020-2031)
  • 8.2 Europe Contraceptives Sales Quantity by End User (2020-2031)
  • 8.3 Europe Contraceptives Market Size by Country
    • 8.3.1 Europe Contraceptives Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Contraceptives Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Contraceptives Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Contraceptives Sales Quantity by End User (2020-2031)
  • 9.3 Asia-Pacific Contraceptives Market Size by Region
    • 9.3.1 Asia-Pacific Contraceptives Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Contraceptives Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Contraceptives Sales Quantity by Type (2020-2031)
  • 10.2 South America Contraceptives Sales Quantity by End User (2020-2031)
  • 10.3 South America Contraceptives Market Size by Country
    • 10.3.1 South America Contraceptives Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Contraceptives Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Contraceptives Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Contraceptives Sales Quantity by End User (2020-2031)
  • 11.3 Middle East & Africa Contraceptives Market Size by Country
    • 11.3.1 Middle East & Africa Contraceptives Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Contraceptives Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Contraceptives Market Drivers
  • 12.2 Contraceptives Market Restraints
  • 12.3 Contraceptives Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Contraceptives and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Contraceptives
  • 13.3 Contraceptives Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Contraceptives Typical Distributors
  • 14.3 Contraceptives Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Contraceptives market size was valued at US$ 2066 million in 2024 and is forecast to a readjusted size of USD 2442 million by 2031 with a CAGR of 2.4% during review period.
    Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
    Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
    The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
    This report is a detailed and comprehensive analysis for global Contraceptives market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Contraceptives market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2020-2031
    Global Contraceptives market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2020-2031
    Global Contraceptives market size and forecasts, by Type and by End User, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2020-2031
    Global Contraceptives market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Contraceptives
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Contraceptives market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Contraceptives market is split by Type and by End User. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Pills
    Injectable
    Condoms
    Vaginal Rings
    IUDs
    Subdermal Implants
    Others
    Market segment by End User
    15–24 years
    25–34 years
    35–44 years
    Above 44 years
    Major players covered
    Bayer AG
    Pfizer, Inc
    Teva Pharmaceutical Industries Ltd
    Merck & Co., Inc
    Actavis, Inc.
    Johnson & Johnson
    Gedeon Richter
    Novo Nordisk A/S
    ZiZhu
    Baijingyu
    Huazhong
    Sine
    Reckitt
    AbbVie
    Church & Dwight
    The Cooper Companies
    TherapeuticsMD
    Afaxys
    Mithra Pharmaceuticals
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Contraceptives product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Contraceptives, with price, sales quantity, revenue, and global market share of Contraceptives from 2020 to 2025.
    Chapter 3, the Contraceptives competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Contraceptives breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by End User, with sales market share and growth rate by Type, by End User, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Contraceptives market forecast, by regions, by Type, and by End User, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Contraceptives.
    Chapter 14 and 15, to describe Contraceptives sales channel, distributors, customers, research findings and conclusion.

    Buy now